Euroopa Liit -
eesti -
EMA (European Medicines Agency)
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastilised ained - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
Eesti -
eesti -
Ravimiamet
carmustine accord infusioonilahuse kontsentraadi pulber ja lahusti
accord healthcare b.v. - karmustiin - infusioonilahuse kontsentraadi pulber ja lahusti - 100mg 10tk; 100mg 1tk
Eesti -
eesti -
Ravimiamet
carustine süstelahuse pulber
mediclone biotech pvt.ltd - karmustiin - süstelahuse pulber - 100mg 1tk
Eesti -
eesti -
Ravimiamet
carustine süstelahuse pulber
khandelwal laboratories pvt. ltd. - karmustiin - süstelahuse pulber - 100mg 1tk
Eesti -
eesti -
Ravimiamet
caroma süstelahuse pulber
mediclone biotech pvt.ltd - karmustiin - süstelahuse pulber - 100mg 1tk